Sign In
Buy DGX
$235.84
+2.12 (+0.91%)
At Close: Aug 05, 2026
Quest Diagnostics (DGX) Gains From New M&As Amid Competition
12:10pm, Friday, 21'st Jun 2024
In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share gains driven by the competitive strength of its scale and innovati
Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024
03:00pm, Wednesday, 19'th Jun 2024
SECAUCUS, N.J. , June 19, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2024 financial res
Quest Diagnostics' (DGX) New Buyout Ramps Up Cancer Diagnosis
10:01am, Tuesday, 18'th Jun 2024
Quest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption of AI and digital pathology to improve cancer diagnosis.
PathAI remains an independent company, focused on developing innovative AI and digital pathology solutions SECAUCUS, N.J. and BOSTON , June 11, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a le
Circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) can reduce costs by up to 21% across health plan populations when half of eligible patients with stage II colorectal cancer are
Why Is Quest Diagnostics (DGX) Up 3.1% Since Last Earnings Report?
12:36pm, Thursday, 23'rd May 2024
Quest Diagnostics (DGX) reported earnings 30 days ago. What's next for the stock?
Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors
04:15pm, Thursday, 16'th May 2024
SECAUCUS, N.J. , May 16, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced that its Board of Directors has elected Robert (Rob
Quest Diagnostics Declares Quarterly Cash Dividend
05:45pm, Wednesday, 15'th May 2024
SECAUCUS, N.J. , May 15, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend
Workforce Drug Test Cheating Surged in 2023, Finds Quest Diagnostics Drug Testing Index Analysis of Nearly 10 Million Drug Tests
08:43am, Wednesday, 15'th May 2024
Overall Drug Positivity Holds Steady at Historically High Rates while Marijuana Positivity Continued Upward Climb in the General U.S. Workforce Marijuana Positivity in the General U.S. Workforce Escal
Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference
04:50pm, Tuesday, 07'th May 2024
SECAUCUS, N.J. , May 7, 2024 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak
Quest Diagnostics (DGX) Grows in Digital Pathology With New Deal
12:26pm, Tuesday, 07'th May 2024
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
Quest Diagnostics Names Murali Balakumar Senior Vice President and Chief Information and Digital Officer
09:40am, Monday, 06'th May 2024
SECAUCUS, N.J. , May 6, 2024 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, announced today that Murali Balakumar, a veteran information technol
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
11:46am, Thursday, 02'nd May 2024
Investors are optimistic about Quest Diagnostics (DGX) on strong legacy business growth.
Quest Diagnostics (DGX) Inks Deal to Acquire PathAI Diagnostics
10:05am, Thursday, 02'nd May 2024
Quest Diagnostics' (DGX) latest transaction combines its oncology expertise and scale with PathAI's AI and digital pathology innovations.
Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce cost
